•  
  •  
 

Abstract

Introduction. Geriatric syndromes is associated with poor survival, poor quality of life and increased chemotoxicity risk in elderly receiving chemotherapy. Geriatric syndromes is currently not routinely evaluated in pre-chemotherapy clinical setting. This study aimed to identify the prevalence of some geriatric syndromes in elderly patients undergoing chemotherapy.Methods. This study is part of primary study investigating geriatric syndromes in elderly with cancer. A descriptive cross sectional study during March 2020 – March 2021 was conducted to elderly patients before chemotherapy administration in Cipto Mangunkusumo Hospital, a national referral hospital in Jakarta. Patients were recruited consecutively. Patients underwent Comprehensive Geriatric Assesment (CGA), including nutritional, depression, sarcopenia risk assessment, frailty, cognitive assessment, as well as medication review.Results. Total of140 elderly subjects were recruited with mean age of 66 years old. 52% subjects were women and 67% with solid tumor. As many as 80% subjects were having malnutrition, 40,6% were frailt, 40,3% were at high risk of sarcopenia, 14,1% with depression, and 19,1% were having cognitive impairment. Of all subjects, 24,1% have more than 3 diagnosis of geriatric syndromes.Conclusion. As geriatric syndromes are prevalent among elderly subjects receiving chemotherapy, routine identification would be useful to improve cancer treatment result.

References

1. American Cancer Society. Estimated number of deaths for the four major cancers by sex and age group.Atlanta, Georgia: American Cancer Society; 2017. p.1–2.2. Kementrian Kesehatan RI. Hasil utama RISKESDAS 2018. Jakarta: Kementerian Kesehatan RI; 2018. 3. Inouye S, Studenski S, Tinetti M, Kuchel G. Geriatric syndromes: clinical, research and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780-91.4. Mohile S, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L. Association of cancer with geriatric syndromes in older medicare beneficiaries. J Clin Oncol. 2011;29(11):1458-64.5. Limpawattana P, Phimson K, Sookprasert ,Sirthanaphol W, Chindaprasirt J. Prevalence of geriatric syndromes in elderly cancer patients receiving chemotherapy. Curr Gerontol Geriatr Res. 2020;2020:9347804.6. Huang CC, Lee LD, Yang DC, Shih HI, Sun YC, Chang CM. Association between geriatric syndromes and mortality in community dwelling elderly: results of a national longitudinal study in Taiwan. J Am Med Dir Assoc. 2017;18(3):246-51.7. Djedi D, Bouzidi K. Use of comprehensive geriatric assesment parameters to predict a chemotherapy toxicity in elderly patients with colorectal cancer: a prospective monocenter study. Ann Oncol. 2012;23:221.8. Koroukian SM, Murray P, Madigan E. Comorbidity, disability and geriatric syndromes in elderly patients receiving home health care. J Clin Oncol. 2006;24:2304-10.9. Allan C, Valkanova V, Ebmeier K. Depression in older people is underdiagnosed. Practitioner. 2014;258(1771):19-22.10. Saracino R, Weinberger M, Roth A, Hurria A, Nelson C. Assessing depression in a geriatric cancer population. Psychooncology. 2017;26(10):1484-90.11. Rostoft S. Integration of geriatric assessment in the care of patients with gastrointestinal malignancies. Visc Med. 2017;33(4):275–80.12. Kalsi T, Babic-Illman G, Ross PJ, Maisey NR, Hughes S, Fields P, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015;112(9):1435–44. 13. Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603. 14. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752-62.15. Handfort C, Clegg A, Young C. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091-1101.16. Runzer CF. Frailty and vulnerability as predictors of chemotherapy toxicity in Peru older adults. J Nutr Health Aging. 2020;24(9):966-72.17. Torres C, Hsu T. Comprehensive geriatric assessment in the older adult with cancer: a review. Eur Urol Focus. 2017;3(4-5):330-9.18. Feliu J, Heredia SV, Girones R. Can we avoid the toxicity of chemotherapy in elder cancer patients?Crit Rev Oncol Hematol. 2018;131:16-23

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.